FIELD: medicine.
SUBSTANCE: invention relates to method of enhancing prolonged februfungal action, increase of februfungal activity and reduction of toxicity of salicylates by introduction in therapeutic dose as salicylate of allyl ether of acetylsalicylic acid. Introduction of allyl gragment into carboxyl group of acetylsalicylic acid molecule allows to enhance prolonged februfungal action and reduce toxicity of acetylsalicylic acid.
EFFECT: application of allyl ether of acetylsalicylic acid as antipyretic will allow to reduce therapeutic dose of acetylsalicylic acid and reduce risk of development of side effects connected with intake of salicylates.
1 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
DIALKYL- β -(O-SALICYLOYL)ETHYLPHOSPHONATES HAVING ANTITHERMIC ACTIVITY | 2009 |
|
RU2420532C1 |
COMPLEX OF PECTIN BIOPOLYMER AND ACETYLSALISYLIC ACID | 2012 |
|
RU2503455C1 |
WATER-SOLUBLE SALAMIDE DERIVATIVE POSSESSING TRANQUILISING, NOOTROPIC AND ANALGESIC ACTIVITY | 2012 |
|
RU2540464C2 |
AGENT POSSESSING ANTIAGGREGANT, CYTOPROTECTIVE AND ANTIOXIDANT ACTIVITY | 2018 |
|
RU2694061C1 |
POLYMERIC WATER-SOLUBLE ANALOG OF ACETYL-SALICYLIC ACID AND METHOD OF ITS SYNTHESIS | 2000 |
|
RU2201234C2 |
COMPLEX COMPOUND EXHIBITING ANTIFLAMMATORY AND ANTIULCEROUS ACTIVITY | 0 |
|
SU1566700A1 |
METHOD OF LIVER PROTECTION FROM XENOBIOTICS IN EXPERIMENT | 2000 |
|
RU2195936C2 |
RIFAMPICIN-BASED MEDICATION WITH PROLONGED ACTION FOR TREATMENT OF RESISTENT FORMS OF TUBERCULOSIS | 2010 |
|
RU2418585C1 |
METHOD FOR SALICYLATES QUANTIFICATION IN BLOOD PLASMA | 2016 |
|
RU2622996C1 |
METHYL 6-ACETYL-7-(2,5-DIMETOXYPHENYL)-4,7-DIHYDROTETRASOLO[1,5-a]PYRIMIDINE-5-CARBOXYLATE, DEMONSTRATING ANTI-FEVER ACTIVITY | 2009 |
|
RU2413730C1 |
Authors
Dates
2010-02-27—Published
2008-05-26—Filed